Surgical tactics for esophageal cancer with complete pathomorphosis after chemoradiotherapy
Authors:
- B. V. SiguaBSB. V. Sigua
- A. A. KurkovAKA. A. Kurkov
- A. V. BelyaevaABA. V. Belyaeva
- Zh. V. BryantsevaZBZh. V. Bryantseva
- A. I. ArsenievAAA. I. Arseniev
- E. L. LatariyaELE. L. Latariya
- O. B. TcelykovskaiaOTO. B. Tcelykovskaia
- I. P. MavidiIMI. P. Mavidi
- K. V. ArutyunyanKAK. V. Arutyunyan
- S. A. VinnichukSVS. A. Vinnichuk
- V. P. ZemlyanoyVZV. P. Zemlyanoy
Open Access
- 26 March 2024
- journal article
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 183 (1) , 42-46
Abstract
Esophageal cancer is an oncological disease with a poor prognosis due to late diagnosis and detection of the tumor at a late stage. At present, the combined method of treatment is generally accepted for this pathology, starting from stage IIA. Preoperative chemoradiation therapy in this approach helps to achieve not only partial but also complete regression of the tumor. The question of the necessity of surgical tactics in this group of patients, due to the lack of clear recommendations, remains controversial at present. The article presents a successful case of neoadjuvant chemoradiation therapy, which made it possible to achieve not only clinical, but also complete pathomorphological regression of the tumor. This tumor response to chemoradiation therapy occurs in less than a third of all patients with esophageal cancer. Despite this, complete regression of the tumor does not mean recovery.Keywords
This publication has 11 references indexed in Scilit:
- The impact of refusing esophagectomy for treatment of locally advanced esophageal adenocarcinomaJTCVS Open, 2023
- Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040Thoracic Cancer, 2022
- Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysisRadiation Oncology, 2021
- Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialJournal of Clinical Oncology, 2021
- Management of Locally Advanced Esophageal CancerJournal of Nepal Medical Association, 2021
- A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESOPRESSO)Anticancer Research, 2019
- Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2019
- Oesophageal carcinomaThe Lancet, 2013
- A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)Annals of Surgical Oncology, 2011